Literature DB >> 27847970

Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry.

Nikolaus A Haas1,2, Laura Kock3, Harald Bertram4, Regina Boekenkamp5, Daniel De Wolf6, Igor Ditkivskyy7, Matthias W Freund8, Marc Gewillig9, Christoph M Happel3, Ulrike Herberg10, Edvard Karthasyan11, Rainer Kozlik-Feldmann12, Oliver Kretschmar13, Yulia Kuzmenko14, Ornella Milanesi15, Goetz Mueller16, Giacomo Pongiglione17, Stephan Schubert18, Gleb Tarusinov19, Christoph Kampmann20.   

Abstract

In August 2010, the Nit-Occlud® Lê (EUREVECO) became available for transcatheter coil occlusion of ventricular septal defects (VSDs). Retrospective European Registry for VSD Closure using the Nit-Occlud® Lê-VSD-Coil; analysis of the feasibility, results, safety and follow-up of VSD-closure over a 3-year period in 18 European centers. In 102 of 111 patients (female 66), successful VSD closure was performed (mean age 8.2 years, mean weight 28.82 kg), 81 perimembranous VSDs (48 with aneurysm), 30 muscular VSDs, mean procedure time was 121.1 min, and mean fluoroscopy time was 26.3 min. Short- and midterm term follow-up was possible in 100/102 patients, there was 1 embolization and 1 explantation after 24 months. Immediate complete closure occurred in 49 of 101 patients (48.5%), trivial residual shunt was present in 51 (50.0%), closure rate was 95% after 6 months and 97% after 1 year. Out of the 102 patients, there were 2 severe complications (1.8%) (1 severe hemolysis, 1 embolization) and 8 moderate/transient (=7.2%) including 1 transient AV block. During a mean follow-up period of 31.3 months (range 24-48) and a total follow-up time of 224.75 patient years, no further problems occurred. VSD closure with the Nit-Occlud® Lê VSD coil is feasible and safe with a minimal risk of severe side effects. The long-term effects and safety require further clinical follow-up studies.

Entities:  

Keywords:  Congenital heart defects; EUREVECO; Interventional VSD closure; Muscular VSD; Nit-Occlud® Lê-VSD-Coil; Perimembranous VSD

Mesh:

Year:  2016        PMID: 27847970     DOI: 10.1007/s00246-016-1502-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  31 in total

1.  Transcatheter closure of the perimembranous ventricular septal defect-preclinical trial of a new Amplatzer device.

Authors:  John L Bass; Daniel Gruenstein
Journal:  Catheter Cardiovasc Interv       Date:  2011-12-12       Impact factor: 2.692

2.  Transvascular closure of single and multiple muscular ventricular septal defects in neonates and infants < 20 kg.

Authors:  Peter Zartner; Claus Christians; Jan-Christian Stelter; Viktor Hraška; Martin B E Schneider
Journal:  Catheter Cardiovasc Interv       Date:  2013-11-09       Impact factor: 2.692

Review 3.  A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD).

Authors:  Linqi Yang; Bee-Choo Tai; Lay Wai Khin; Swee Chye Quek
Journal:  J Interv Cardiol       Date:  2014-04-29       Impact factor: 2.279

4.  Temporary atrioventricular complete block that develops following the transcatheter closure of ventricular septal defect.

Authors:  Sevcan Erdem; Alev Kizlltaş; Osman Küçükosmanoğlu; Nazan Ozbarlas
Journal:  Turk J Pediatr       Date:  2012 Jan-Feb       Impact factor: 0.552

5.  The results of transcatheter closure of VSD using Amplatzer® device and Nit Occlud® Lê coil.

Authors:  Paweena Chungsomprasong; Kritvikrom Durongpisitkul; Chodchanok Vijarnsorn; Jarupim Soongswang; Trong Phi Lê
Journal:  Catheter Cardiovasc Interv       Date:  2011-06-06       Impact factor: 2.692

6.  Preoperative transcatheter closure of congenital muscular ventricular septal defects.

Authors:  N D Bridges; S B Perry; J F Keane; S A Goldstein; V Mandell; J E Mayer; R A Jonas; A R Casteneda; J E Lock
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

7.  Transcatheter trans-septal antegrade closure of muscular ventricular septal defects in young children.

Authors:  Nageswara Rao Koneti; Sudeep Verma; Shweta Bakhru; Karunakar Vadlamudi; Pallavi Kathare; Raghava Raju Penumatsa; Shakeel Qureshi
Journal:  Catheter Cardiovasc Interv       Date:  2013-07-01       Impact factor: 2.692

8.  Transcatheter coil occlusion of perimembranous ventricular septal defects.

Authors:  Shunji Nogi; Noriyuki Haneda; Hideshi Tomita; Kenji Yasuda
Journal:  Catheter Cardiovasc Interv       Date:  2008-11-01       Impact factor: 2.692

9.  [Transcatheter closure of congenital ventricular septal defects].

Authors:  P Ewert; O Kretschmar; B Peters; H Abdul Khaliq; N Nagdyman; I Schulze-Neick; J Bass; T P Lê; P E Lange
Journal:  Z Kardiol       Date:  2004-02

10.  Device closure of muscular ventricular septal defects in infants less than one year of age using the Amplatzer devices: feasibility and outcome.

Authors:  Karim A Diab; Qi-Ling Cao; Bassem N Mora; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2007-07-01       Impact factor: 2.692

View more
  13 in total

1.  Transcatheter perimembranous ventricular septal defect closure under transthoracic echocardiographic guidance without fluoroscopy.

Authors:  Shouzheng Wang; Wenbin Ouyang; Yao Liu; Fengwen Zhang; Gaili Guo; Guangzhi Zhao; Xiangbin Pan
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Percutaneous closure of perimembranous ventricular septal defect using patent ductus arteriosus occluders.

Authors:  Hieu Lan Nguyen; Quang Tan Phan; Dung Duc Doan; Linh Huynh Dinh; Hieu Ba Tran; Saima Sharmin; Julian Johny Thottian; Hoyoun Won; Wang Soo Lee; Seung Yong Shin; Truong Quang Nguyen; Sang Wook Kim
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

3.  Mid-term results of transcatheter closure of ventricular septal defect using Nit-Occlud Lê ventricular septal defect coil, single-center experience.

Authors:  Sahar El Shedoudy; Eman El-Doklah
Journal:  J Saudi Heart Assoc       Date:  2018-11-17

4.  Transcatheter Closure of Perimembranous and Intracristal Ventricular Septal Defects Using Amplatzer Duct Occluder II in Children.

Authors:  Shenrong Liu; Wenqian Zhang; Junjie Li; Shushui Wang; Mingyang Qian; Jijun Shi; Yumei Xie; Zhiwei Zhang
Journal:  J Interv Cardiol       Date:  2021-09-11       Impact factor: 2.279

5.  Transcatheter Closure of Perimembranous Ventricular Septal Defect Using the Lifetech Konar-Multi Functional Occluder: Early to Midterm Results of the Indonesian Multicenter Study.

Authors:  Rahmat Budi Kuswiyanto; Eka Gunawijaya; Mulyadi M Djer; Mahrus A Rahman; Indah K Murni; Rubiana Sukardi; Alit Utamayasa; Rizky Ardiansyah; Ria Nova; Sri Liliyanti; Sri E Rahayuningsih; Shirley L Anggriawan; Tri Yanti Rahayuningsih; Dyahris Koentartiwi; Renny Soewarniaty; Venny Kartika Yantie; Sasmito Nugroho; Taufiq Hidayat; Teddy Ontoseno; Tina C Tobing; Muhamad Ali; Muhammad Hasan Bashari; Denny S Yosy; Nadya Arafuri; Dany Hilmanto; Piprim B Yanuarso; Najib Advani; Sudigdo Sastroasmoro; Sukman Tulus Putra
Journal:  Glob Heart       Date:  2022-02-24

6.  Long-Term Outcome of Transcatheter Device Closure of Perimembranous Ventricular Septal Defects.

Authors:  Krishna D Mandal; Danyan Su; Yusheng Pang
Journal:  Front Pediatr       Date:  2018-05-03       Impact factor: 3.418

Review 7.  Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects.

Authors:  P Syamasundar Rao; Andrea D Harris
Journal:  F1000Res       Date:  2018-04-26

8.  Subacute reconstruction using flap transfer for complex defects of the upper extremity.

Authors:  Yongqiang Kang; Xiaoyun Pan; Yongwei Wu; Yunhong Ma; Jun Liu; Yongjun Rui
Journal:  J Orthop Surg Res       Date:  2020-04-07       Impact factor: 2.359

9.  Assessment of left ventricular systolic function after VSD transcatheter device closure using speckle tracking echocardiography.

Authors:  Yasmin Abdelrazek Ali; Maryam Araby Hassan; Azza Abdallah El Fiky
Journal:  Egypt Heart J       Date:  2019-08-05

10.  Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients.

Authors:  F Berger; S Schubert; M Bergmann; C P Germann; J Nordmeyer; B Peters
Journal:  Pediatr Cardiol       Date:  2020-10-03       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.